Freestone Grove Partners’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,931
Closed -$119K 731
2024
Q4
$119K Buy
+13,931
New +$119K ﹤0.01% 556